The Rigaku Group’s XwinSys Changes its Name to Rigaku Semiconductor Instruments
XwinSys Technology Development Ltd, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), changed its name to Rigaku Semiconductor Instruments Ltd (hereinafter “RSI”). Established in 2012 with its headquarters in Israel, RSI joined the Rigaku Group in 2019. RSI conducts R&D in and manufacturing of semiconductor metrology tool that […]
Hologic Announces Martin Madaus as Member of Its Board of Directors
Hologic, Inc. recently announced that Martin Madaus has been elected to the Company’s Board of Directors, effective December 6, 2024. Dr. Madaus was also appointed to the Compensation Committee and the Nominating and Corporate Governance Committee effective December 6, 2024. Dr. Madaus, who has more than 30 years of diagnostics and life sciences industry experience, […]
Tamga: Innovations and Challenges to Transform the Fintech Industry
The fintech industry continues to evolve dynamically, offering users new solutions that simplify access to financial services. One of the prime examples of this evolution is Tamga, which is successfully tapping into the global trends of digitalisation of finance. Having gone from marketing solutions for fintech to launching full-fledged financial products, Tamga demonstrates how innovation […]
EIB backs Protembis technology with EUR 20 million to protect the brain during cardiac surgery
The European Investment Bank (EIB) is providing €20 million in venture debt financing to German medical technology start-up Protembis. The company plans to use the money to advance the development of a novel system that protects the brain during certain cardiac procedures. Specifically, the funds are intended to enable clinical trials, research, development and the […]
Lenovo Names Dr Tolga Kurtoglu as New Chief Technology Officer
Global technology leader Lenovo has announced the appointment of Dr. Tolga Kurtoglu as the company’s new Chief Technology Officer (CTO), succeeding Dr. Yong Lui to further accelerate the group’s technology vision and AI leadership. Lenovo also announced the formation of a new Emerging Technologies Group, which will help the company anticipate emerging technology trends and […]
Trinasolar inks a long term agreement with Universidad Politécnica de Madrid
Trinasolar has announced the signing of a long-term collaboration agreement with the Institute of Solar Energy at Universidad Politécnica de Madrid (IES-UPM). The agreement, signed on June 26, is a milestone in Trinasolar’s involvement with leading universities, highlighting the commitment of all concerned to education, research and innovation in solar energy. The agreement was signed on the campus […]
Merck Signs MoU with KAIST to Further Scientific Partnership in South Korea
Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with the Korea Advanced Institute of Science and Technology (KAIST). The academia-industry cooperation aims to advance the research and development ecosystem in South Korea for industrial applications. “Our collaboration with KAIST is an important step towards accelerating the biotechnology ramp-up […]
Luxembourg signs a MoU with Pony.ai to advance autonomous mobility
Pony.ai, a leading global autonomous mobility company, held a Memorandum of Understanding (MoU) signing ceremony today with the Government of the Grand Duchy of Luxembourg (“The Government”) to advance the development of autonomous mobility in Luxembourg. The MoU was signed by Pony.ai Co-Founder and CEO Dr. James Peng and Luxembourg’s Minister of the Economy Lex […]
Sridhar Ramaswamy Named Chief Executive Officer of Snowflake
Snowflake, the Data Cloud company, announced yesterday that Frank Slootman has decided to retire as Chief Executive Officer and Sridhar Ramaswamy has been named as Chief Executive Officer and member of the Board of Directors effective immediately. Mr. Ramaswamy previously held the position of Senior Vice President of AI at Snowflake. Frank Slootman will continue […]
Gilead Sciences announces the acquisition of CymaBay Therapeutics
Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced yesterday a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of primary biliary cholangitis (PBC) including pruritus, complements Gilead’s existing liver […]
